TAKEDA PHARM.CO.LTD. revenue breakdown overview

TAKEDA PHARM.CO.LTD. revenue for the last year amounted to 27.97 B EUR, the most of which — 7.60 B EUR — came from its highest performing source at the moment, Gastrointestinal, the year earlier bringing 6.50 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought TAKEDA PHARM.CO.LTD. 14.61 B EUR, and the year before that — 12.73 B EUR.